NDC 73150-200

UKONIQ

Umbralisib

UKONIQ is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Tg Therapeutics, Inc.. The primary component is Umbralisib Tosylate.

Product ID73150-200_6f6fcaa4-e82f-4850-bf75-b5806f0478af
NDC73150-200
Product TypeHuman Prescription Drug
Proprietary NameUKONIQ
Generic NameUmbralisib
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2021-02-05
Marketing CategoryNDA / NDA
Application NumberNDA213176
Labeler NameTG Therapeutics, Inc.
Substance NameUMBRALISIB TOSYLATE
Active Ingredient Strength260 mg/1
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 73150-200-12

4 CARTON in 1 CASE (73150-200-12) > 12 BOTTLE, PLASTIC in 1 CARTON > 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
Marketing Start Date2021-02-05
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [UKONIQ]

Mark Image

Registration | Serial
Company
Trademark
Application Date
UKONIQ
UKONIQ
88711946 not registered Live/Pending
TG Therapeutics
2019-12-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.